Literature DB >> 1239214

Sevoflurane: a new inhalational anesthetic agent.

R F Wallin, B M Regan, M D Napoli, I J Stern.   

Abstract

Laboratory screening of a series of halogenated methyl isopropyl ethers revealed sevoflurane (fluoromethyl-1,1,1,3,3,3,-hexafluroro-2-propyl ether) as a potent nonexplosive inhalational anesthetic agent. Sevoflurance, a pleasant-smelling liquid, boils at 58.5 degrees C at 760 torr and has a vapor pressure of 200 torr at 25 degrees C. It is nonflammable in air and has lower flammability limits of 11 vols percent in O2 and 10 vols percent in N2O. Sevoflurane exhibits limited chemical reactivity in vitro; it is subject to slight but measurable hydrolysis, and reacts with soda lime to form traces of related ethers. It provides rapid anesthetic induction and recovery consistent with its low distribution coefficients (blood:gas, 0.6; corn oil:gas, 41.6; olive oil:gas, 53.4). In dogs, anesthetic concentrations of sevoflurane did not produce spontaneous cardiac arrhythmias and did not sensitize the heart to epinephrine. Electroencephalographic patterns were similar to those observed during anesthesia with halothane. In rats, small increases in the urinary excretion of inorganic fluoride ion occurred during the first 24 hours after anesthesia. Subacute studies in dogs and rats, using closed-circle absorption with soda lime, revealed no toxicologically significant changes in animals anesthetized frequently for 2 weeks. Sevoflurane appears to be a unique volatile anesthetic agent worthy of further study.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1239214     DOI: 10.1213/00000539-197511000-00021

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  53 in total

1.  Comparative study of sevoflurane with other inhalation agents.

Authors:  Y Kubota
Journal:  Anesth Prog       Date:  1992

2.  Interactions between volatile anesthetics and dipalmitoyl phosphatidylcholine liposomes as studied by fluorometry with a thiacarbocyanine dye.

Authors:  I Tsukamoto; S Yokono; Y Shirakawa; H Kinoshita; H Komatsu; M Aibiki; K Ogli
Journal:  J Anesth       Date:  1992-01       Impact factor: 2.078

3.  The effect of sevoflurane on somatically induced sympathetic reflexes.

Authors:  K Yanase; K Meguro; A Sato; Y Sato
Journal:  J Anesth       Date:  1988-09-01       Impact factor: 2.078

4.  The comparative cardiovascular effects of sevoflurane with halothane and isoflurane.

Authors:  T Kazama; K Ikeda
Journal:  J Anesth       Date:  1988-03-01       Impact factor: 2.078

5.  A clinical trial of sevoflurane in children for herniorrhaphy.

Authors:  H Morisaki; G Suzuki; N Miyazawa; Y Kiichi; T Misaki; A Suzuki
Journal:  J Anesth       Date:  1988-03-01       Impact factor: 2.078

6.  Comparison of the epinephrine-induced arrhythmogenic effect of sevoflurane with isoflurane and halothane.

Authors:  S Imamura; K Ikeda
Journal:  J Anesth       Date:  1987-03-01       Impact factor: 2.078

7.  Effects of sevoflurane on autonomic nerve activities controlling cardiovascular functions in rats.

Authors:  M Kurosawa; K Meguro; T Nagayama; A Sato
Journal:  J Anesth       Date:  1989-09-01       Impact factor: 2.078

8.  Effects of different speeds of induction with sevoflurane on the EEG in man.

Authors:  M N Avramov; K Shingu; Y Omatsu; M Osawa; K Mori
Journal:  J Anesth       Date:  1987-03-01       Impact factor: 2.078

9.  Factors affecting the rate of disappearance of sevoflurane in Baralyme.

Authors:  D T Wong; J Lerman
Journal:  Can J Anaesth       Date:  1992-04       Impact factor: 5.063

Review 10.  Clinical pharmacokinetics of sevoflurane.

Authors:  M Behne; H J Wilke; S Harder
Journal:  Clin Pharmacokinet       Date:  1999-01       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.